Rationale for a home dialysis virtual ward: design and implementation

BMC Nephrology

Christopher T Chan⁷  Deborah Zimmerman²  Jeffrey Perl⁴  Robert P Pauly³  Matthew Oliver⁸  Adeera Levin¹  Karthik K Tennankore⁶  Michelle Hladunewich⁸  Michael Copland⁵  Joanne M Bargman⁷  Michael E Schachter⁷ 

[1] Department of Medicine, Division of Nephrology, St Paul’s Hospital, 1081 Burrard Street, Vancouver, BC V6Z 1Y6, Canada;Department of Medicine, Division of Nephrology, Ottawa Hospital, University of Ottawa, 1967 Riverside Drive Ottawa, Ottawa, ON K1H 7W9, Canada;Department of Medicine, Division of Nephrology & Transplantation Immunology, University of Alberta, 11-107 Clinical Sciences Building, 8440, 112th Street, Edmonton, AB T6G 2G3, Canada;Department of Medicine, Division of Nephrology, St. Michael’s Hospital, 30 Bond Street, Toronto, ON M5B 1W8, Canada;Department of Medicine, Division of Nephrology, Vancouver General Hospital, University of British Columbia, 855 12th Avenue W, Vancouver, BC V5Z 1M9, Canada;Department of Medicine, Division of Nephrology, QEII Health Sciences Centre, 5820 University Avenue, Halifax, NS B3H 1V7, Canada;Department of Medicine, Division of Nephrology, University Health Network, 200 Elizabeth Street, Toronto, ON M5G 2C4, Canada;Department of Medicine, Division of Nephrology, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON M4N 3M5, Canada

关键词: Patient satisfaction;    Technique survival;    Re-admission;    Home hemodialysis;    Peritoneal dialysis;    Hospital-avoidance;    Patient support;    Home dialysis;    Virtual ward;   

Others  :  1082726
DOI  :  10.1186/1471-2369-15-33

 received in 2013-12-10, accepted in 2014-01-28,  发布年份 2014

【 摘 要 】

Background

Home-based renal replacement therapy (RRT) [peritoneal dialysis (PD) and home hemodialysis (HHD)] offers independent quality of life and clinical advantages compared to conventional in-center hemodialysis. However, follow-up may be less complete for home dialysis patients following a change in care settings such as post hospitalization. We aim to implement a Home Dialysis Virtual Ward (HDVW) strategy, which is targeted to minimize gaps of care.

Methods/design

The HDVW Pilot Study will enroll consecutive PD and HHD patients who fulfilled any one of our inclusion criteria: 1. following discharge from hospital, 2. after interventional procedure(s), 3. prescription of anti-microbial agents, or 4. following completion of home dialysis training. Clinician-led telephone interviews are performed weekly for 2 weeks until VW discharge. Case-mix (modified Charlson Comorbidity Index), symptoms (the modified Edmonton Symptom Assessment Scale) and patient satisfaction are assessed serially. The number of VW interventions relating to eight pre-specified domains will be measured. Adverse events such as re-hospitalization and health-services utilization will be ascertained through telephone follow-up after discharge from the VW at 2, 4, 12 weeks. The VW re-hospitalization rate will be compared with a contemporary cohort (matched for age, gender, renal replacement therapy and co-morbidities). Our protocol has been approved by research ethics board (UHN: 12-5397-AE). Written informed consent for participation in the study will be obtained from participants.

Discussion

This report serves as a blueprint for the design and implementation of a novel health service delivery model for home dialysis patients. The major goal of the HDVW initiative is to provide appropriate and effective supports to medically complex patients in a targeted window of vulnerability.

Trial registration

(NCT01912001).

【 授权许可】

   
2014 Schachter et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]McFarlane PA, Bayoumi AM, Pierratos A, Redelmeier DA: The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis. Kidney Int 2003, 64(3):1004-1011.
• [2]Lockridge RS Jr, Spencer M, Craft V, Pipkin M, Campbell D, McPhatter L, Albert J, Anderson H, Jennings F, Barger T: Nightly home hemodialysis: five and one-half years of experience in Lynchburg, Virginia. Hemodial Int 2004, 8(1):61-69.
• [3]Rubin HR, Fink NE, Plantinga LC, Sadler JH, Kliger AS, Powe NR: Patient ratings of dialysis care with peritoneal dialysis vs hemodialysis. JAMA 2004, 291(6):697-703.
• [4]Juergensen E, Wuerth D, Finkelstein SH, Juergensen PH, Bekui A, Finkelstein FO: Hemodialysis and peritoneal dialysis: patients’ assessment of their satisfaction with therapy and the impact of the therapy on their lives. Clin J Am Soc Nephrol 2006, 1(6):1191-1196.
• [5]Johansen KL, Zhang R, Huang Y, Chen SC, Blagg CR, Goldfarb-Rumyantzev AS, Hoy CD, Lockridge RS Jr, Miller BW, Eggers PW, et al.: Survival and hospitalization among patients using nocturnal and short daily compared to conventional hemodialysis: a USRDS study. Kidney Int 2009, 76(9):984-990.
• [6]Kjellstrand CM, Buoncristiani U, Ting G, Traeger J, Piccoli GB, Sibai-Galland R, Young BA, Blagg CR: Short daily haemodialysis: survival in 415 patients treated for 1006 patient-years. Nephrol Dial Transplant 2008, 23(10):3283-3289.
• [7]Pauly RP, Gill JS, Rose CL, Asad RA, Chery A, Pierratos A, Chan CT: Survival among nocturnal home haemodialysis patients compared to kidney transplant recipients. Nephrol Dial Transplant 2009, 24(9):2915-2919.
• [8]Weinhandl ED, Foley RN, Gilbertson DT, Arneson TJ, Snyder JJ, Collins AJ: Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. Clin J Am Soc Nephrol 2010, 21(3):499-506.
• [9]Weinhandl ED, Liu J, Gilbertson DT, Arneson TJ, Collins AJ: Survival in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients. J Am Soc Nephrol 2012, 23(5):895-904.
• [10]Lacson E Jr, Xu J, Suri RS, Nesrallah G, Lindsay R, Garg AX, Lester K, Ofsthun N, Lazarus M, Hakim RM: Survival with three-times weekly in-center nocturnal versus conventional hemodialysis. J Am Soc Nephrol 2012, 23(4):687-695.
• [11]Komenda P, Gavaghan MB, Garfield SS, Poret AW, Sood MM: An economic assessment model for in-center, conventional home, and more frequent home hemodialysis. Kidney Int 2012, 81(3):307-313.
• [12]Guo A, Mujais S: Patient and technique survival on peritoneal dialysis in the United States: evaluation in large incident cohorts. Kidney Int Suppl 2003, 88:S3-S12.
• [13]Cafazzo JA, Leonard K, Easty AC, Rossos PG, Chan CT: Patient-perceived barriers to the adoption of nocturnal home hemodialysis. Clin J Am Soc Nephrol 2009, 4(4):784-789.
• [14]Pauly RP, Maximova K, Coppens J, Asad RA, Pierratos A, Komenda P, Copland M, Nesrallah GE, Levin A, Chery A, et al.: Patient and technique survival among a Canadian multicenter nocturnal home hemodialysis cohort. Clin J Am Soc Nephrol 2010, 5(10):1815-1820.
• [15]Piccoli GB FM, Consiglio V, Scognamiglio S, Deagostini MC, Randone O, Vigotti FN, Calderale PM: Why home hemodialysis? A systematic “marketing” analysis. J Nephrol 2012, 25(2):159-169.
• [16]Coleman EA, Parry C, Chalmers S, Min SJ: The care transitions intervention: results of a randomized controlled trial. Arch Intern Med 2006, 166(17):1822-1828.
• [17]Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW: The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med 2003, 138(3):161-167.
• [18]Bisognano M, Boutwell A: Improving transitions to reduce readmissions. Front Health Serv Manage 2009, 25(3):3-10.
• [19]Jencks SF, Williams MV, Coleman EA: Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 2009, 360(14):1418-1428.
• [20]Lewis GBM, Vaithianathan R, Steventon A, Georghiou T, Billings J, Dixon J: Do ‘virtual wards’ reduce rates of unplanned hospital admissions, and at what cost? A research protocol using propensity matched controls. Int J Integr Care 2011, 11(18):1-8.
• [21]Hemmelgarn BR, Manns BJ, Quan H, Ghali WA: Adapting the Charlson Comorbidity Index for use in patients with ESRD. Am J Kidney Dis 2003, 42(1):125-132.
• [22]Davison SN, Jhangri GS, Johnson JA: Cross-sectional validity of a modified Edmonton symptom assessment system in dialysis patients: a simple assessment of symptom burden. Kidney Int 2006, 69(9):1621-1625.
• [23]Murtagh FE, Addington-Hall JM, Edmonds PM, Donohoe P, Carey I, Jenkins K, Higginson IJ: Symptoms in advanced renal disease: a cross-sectional survey of symptom prevalence in stage 5 chronic kidney disease managed without dialysis. J Palliat Med 2007, 10(6):1266-1276.
• [24]Davison SN: Integrating palliative care for patients with advanced chronic kidney disease: recent advances, remaining challenges. J Palliat Care 2011, 27(1):53-61.
• [25]Oliver MJ, Garg AX, Blake PG, Johnson JF, Verrelli M, Zacharias JM, Pandeya S, Quinn RR: Impact of contraindications, barriers to self-care and support on incident peritoneal dialysis utilization. Nephrol Dial Transplant 2010, 25(8):2737-2744.
• [26]Naylor MD, Brooten D, Campbell R, Jacobsen BS, Mezey MD, Pauly MV, Schwartz JS: Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial. JAMA 1999, 281(7):613-620.
• [27]Drain M: Quality improvement in primary care and the importance of patient perceptions. J Ambul Care Manage 2001, 24(2):30-46.
• [28]Kleefstra SM, Kool RB, Veldkamp CM, der Meer AC W-v, Mens MA, Blijham GH, de Haes JC: A core questionnaire for the assessment of patient satisfaction in academic hospitals in The Netherlands: development and first results in a nationwide study. Qual Saf Health Care 2010, 19(5):e24.